Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial

Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial
复制标题

DOI:
10.1007/s00431-002-0915-y
复制
发表时间:
2002-04-01
影响因子:
3.6
通讯作者:
Saia, OS
Saia, OS
中科院分区:
医学3区
文献类型:
--
作者:
Lago, P;Bettiol, T;Saia, OS

文献摘要

被引文献

相似文献

吲哚美辛(INDO)和最近的布洛芬(IBU)已被用于治疗早产儿血流动力学上显著的动脉导管未闭(PDA)。两者都是环加氧酶阻滞剂,但似乎对局部循环有不同的影响。在一项前瞻性、随机对照研究中,我们比较了INDO和IBU在PDA早期非侵入性治疗中的疗效和安全性。采用多普勒超声心动图对232例伴有呼吸窘迫综合征的早产儿(胎龄23-34周)进行了研究,其中175例在出生后48-72小时有持续的、血流动力学显著的PDA。他们随机接受三次静脉注射剂量的INDO (0.2 mg/kg,间隔12小时)或IBU(第一次10mg /kg剂量,随后两次5mg /kg剂量,间隔24小时),记录导管关闭率、额外治疗需求、副作用和临床病程。两组药物治疗效果相似(INDO组为56/81,69%;IBU组为69/94,73%)。接受INDO治疗的患者血清肌酐显著升高(89+/-24 vs 82+/-20 mmol/l, P=0.03),钠排泄量下降趋势接近显著(3+/-3 vs 4+/-2%, P= 0.08);此外。12/81(15%)的INDO患者和1/94(1%)的IBU患者出现少尿(
Indomethacin (INDO) and, more recently, ibuprofen (IBU) have been used to treat haemodynamically significant patent ductus arteriosus (PDA) in preterm infants. Both are cyclo-oxygenase blockers, but seem to have a different influence on regional circulation. In a prospective, randomised, controlled study, we compared INDO and IBU with regard to efficacy and safety for the early non-invasive treatment of PDA. Doppler echocardiography was used to study 232 preterm infants (gestational age 23-34 weeks) with respiratory distress syndrome of whom 175 had persistent, haemodynamically significant PDA at 48-72 h of life. They were randomised to receive three intravenous doses of either INDO (0.2 mg/kg, at 12 h intervals) or IBU (a first 10 mg/kg dose followed by two doses of 5 mg/kg at 24 h intervals), recording rate of ductal closure, need for additional treatment, side-effects and clinical course. The efficacy of the pharmacological treatment was similar in the two groups (56/81, 69% INDO; 69/94, 73% IBU). Patients treated with INDO showed a significant increase in serum creatinine (89+/-24 versus 82+/-20 mmol/l, P=0.03) and a near-significant tendency for a lower fractional excretion of sodium (3+/-3 versus 4+/-2%, P = 0.08); moreover. 12/81 (15%) INDO patients versus 1/94 (1%) IBU patients became oliguric (